Novel Pharmacologic Targeting of Tight Junctions and Focal Adhesions in Prostate Cancer Cells
Patrick J. Hensley(University of Kentucky), Natasha Kyprianou(Icahn School of Medicine at Mount Sinai)
Cited by 35
Related Papers
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
|Cancer Research|2010|350
Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
|International Journal of Biological Sciences|2014|110
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer
|The Prostate|2006|87